Clinical implications and prognostic value of single and combined biomarkers in endometrial carcinoma

被引:0
|
作者
Li Mingzhu [1 ]
Zhao Lijun [1 ]
Shen Danhua [1 ]
Li Xiaoping [1 ]
Wang Jianliu [1 ]
Wei Lihui [1 ]
机构
[1] Department of Obstetrics and Gynecology, Peking University People’s Hospital
基金
中国国家自然科学基金;
关键词
D O I
暂无
中图分类号
R737.33 [子宫肿瘤];
学科分类号
摘要
Background Endometrial carcinoma is one of the most common gynecological cancers and the incidence has been increasing. This study was to identify the relationship of estrogen receptor(ER), progestrone receptor(PR), P53 protein, Ki-67 and phosphatase and tensin homolog deleted on chromosome ten(PTEN) with endometrial carcinoma, the assessment of these biomarkers and their association with clinicopathological parameters was performed.Methods A total of 198 cases of primary endometrial carcinoma were investigated for ER, PR, Ki-67, P53, and PTEN antigens by immunohistochemical methods. The association of these markers with age, menopause status, histological type, FIGO stage, grading, depth of invasion, lymph node involvement and serum tumor marker was examined.Results The percentages of Ki-67- and P53-negative endometrial tumors were significantly higher in ER-positive compared with ER-negative tumors(both P=0.000). The same trend was evident with PR status. The percentage of PTEN-positive tumors was significantly higher in PR-positive compared with PR-negative tumors(P=0.021), but was no difference in tumors with different ER status. There was no clear association between PTEN positivity and clinicopathological parameters except more relevance with endometrioid histotype(P=0.013). There was a statistically significant difference in the distribution of the different combined biological factors examined in disease-free survival.Conclusions ER and PR status were significant predictors with staging, grading and recurrence. P53 and Ki-67 expression were inversely correlated with both ER and PR expression and have more aggressive clinicopathological features. PTEN expression was inversely correlated with PR expression but not with ER expression. The combined type of ER+PR+P53-PTEN+ was in the majority in endometrial cancer and seemed to be related to better clinical outcome. The combination of ER-PR-P53+PTEN- represented the worst disease-free survival and was strongly associated with poorest survival rate.
引用
收藏
页码:1459 / 1463
相关论文
共 50 条
  • [31] Clinicopathological significance and prognostic value of myoinvasive patterns in endometrial endometrioid carcinoma
    Amalinei, Cornelia
    Aignatoaei, Anda Maria
    Balan, Raluca Anca
    Giusca, Simona Eliza
    Lozneanu, Ludmila
    Avadanei, Elena Roxana
    Caruntu, Irina-Draga
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2018, 59 (01): : 13 - 22
  • [32] Prognostic value of surface involvement (SI) by the tumor in endometrial carcinoma (EC)
    Gupta, D
    Mook, W
    Schilling, D
    ElHilal, A
    Kanbour-Shakir, A
    MODERN PATHOLOGY, 2002, 15 (01) : 197A - 197A
  • [33] PROGNOSTIC VALUE OF CYTOLOGIC EXAMINATION OF PERITONEAL WASHINGS IN PATIENTS WITH ENDOMETRIAL CARCINOMA
    SZPAK, CA
    CREASMAN, WT
    VOLLMER, RT
    JOHNSTON, WW
    ACTA CYTOLOGICA, 1981, 25 (06) : 640 - 646
  • [34] The prognostic value of the tumour protein p53 in endometrial carcinoma
    Sisovsky, V.
    Palkovic, M.
    Bucekova, B.
    Porubsky, J.
    Repiska, V.
    Danihel, L.
    VIRCHOWS ARCHIV, 2009, 455 : 448 - 448
  • [35] PROGNOSTIC VALUE OF CYTOLOGIC EXAMINATION OF PERITONEAL WASHINGS IN PATIENTS WITH ENDOMETRIAL CARCINOMA
    SZPAK, C
    CREASMAN, W
    VOLLMER, RT
    JOHNSTON, WW
    ACTA CYTOLOGICA, 1981, 25 (04) : 447 - 447
  • [36] Prognostic value of surface involvement (SI) by the tumor in endometrial carcinoma (EC)
    Gupta, D
    Mook, W
    Schilling, D
    ElHilal, A
    Kanbour-Shakir, A
    LABORATORY INVESTIGATION, 2002, 82 (01) : 197A - 197A
  • [37] Impact of endometrial carcinoma histotype on the prognostic value of the TCGA molecular subgroups
    Antonio Travaglino
    Antonio Raffone
    Cristina Stradella
    Rosanna Esposito
    Paola Moretta
    Cinzia Gallo
    Giuliana Orlandi
    Luigi Insabato
    Fulvio Zullo
    Archives of Gynecology and Obstetrics, 2020, 301 : 1355 - 1363
  • [38] Molecular classification of endometrial carcinoma on endometrial biopsy: an early prognostic value to guide personalized treatment
    Restaino, Stefano
    Poli, Alice
    Arcieri, Martina
    Mariuzzi, Laura
    Orsaria, Maria
    Tulisso, Angelica
    Pellecchia, Giulia
    Paparcura, Federico
    Petrillo, Marco
    Bogani, Giorgio
    Cianci, Stefano
    Capozzi, Vito Andrea
    Biasioli, Anna
    Buda, Alessandro
    Mauro, Jessica
    Fanfani, Francesco
    Fagotti, Anna
    Driul, Lorenza
    Scambia, Giovanni
    Vizzielli, Giuseppe
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (08) : 1211 - 1216
  • [39] Stage I and II endometrial carcinoma: prognostic factors and surgical implications
    Michel, G
    Morice, P
    Castaigne, D
    Lanoux, P
    Pautier, P
    Lhomme, C
    Gerbaulet, A
    Duvillard, P
    CONTRACEPTION FERTILITE SEXUALITE, 1998, 26 (06): : 452 - 456
  • [40] ENDOMETRIAL CARCINOMA WITH CERVICAL INVOLVEMENT (STAGE-II) - PROGNOSTIC FACTORS AND VALUE OF COMBINED RADIOLOGICAL-SURGICAL TREATMENT
    ONSRUD, M
    AALDERS, J
    ABELER, V
    TAYLOR, P
    GYNECOLOGIC ONCOLOGY, 1982, 13 (01) : 76 - 86